Dr. George Georges
Add to your Care-Team
Dr. George Georges
Dr. George Georges
I specialize in
I have been in practice
My answers and insights have
Helped 20 people
Here are kind words from others
This Thanksgiving, I wanted to share my appreciation for all that you do! Thank you, doctor! :)
I am located at
1959 Ne Pacific St
Seattle , WA 98195
Parkland Memorial Hospital
5201 Harry Hines Boulevard
Dallas , TX 75235
825 Eastlake Ave. E
Seattle , WA 98109
1100 Fairview Ave. N
Seattle , WA 98109
I was educated and trained at
Medical / Graduate School
University of California, San Francisco School of Medicine
Long-term tolerance to kidney allografts after induced rejection of donor hematopoietic chimerism in a preclinical canine model.
Transplantation., Sep;94(6):562-8 (2012)
Pulmonary administration of a water-soluble curcumin complex reduces severity of acute lung injury.
Am. J. Respir. Cell Mol. Biol., Sep;47(3):280-7 (2012)
Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies.
JAMA., Nov;306(17):1874-83 (2011)
Transient proteasome inhibition as a strategy to enhance lentiviral transduction of hematopoietic CD34(+) cells and T lymphocytes: implications for the use of low viral doses and large-size vectors.
J. Biotechnol., Dec;156(3):218-26 (2011)
Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia.
Haematologica., Aug;96(8):1113-20 (2011)
Blood-based detection of radiation exposure in humans based on novel phospho-Smc1 ELISA.
Radiat. Res., Mar;175(3):266-81 (2011)
Antagonistic and agonistic anti-canine CD28 monoclonal antibodies: tools for allogeneic transplantation.
Transplantation., Apr;91(8):833-40 (2011)
Identification of radiation-induced expression changes in nonimmortalized human T cells.
Radiat. Res., Feb;175(2):172-84 (2011)
Mesenchymal stromal cells fail to prevent acute graft-versus-host disease and graft rejection after dog leukocyte antigen-haploidentical bone marrow transplantation.
Biol. Blood Marrow Transplant., Feb;17(2):214-25 (2011)
Outcome of allogeneic hematopoietic cell transplantation from HLA-identical siblings for severe aplastic anemia in patients over 40 years of age.
Biol. Blood Marrow Transplant., Oct;16(10):1411-8 (2010)
Animal models for medical countermeasures to radiation exposure.
Radiat. Res., Apr;173(4):557-78 (2010)
A preclinical model of double- versus single-unit unrelated cord blood transplantation.
Biol. Blood Marrow Transplant., Aug;16(8):1090-8 (2010)
A novel monoclonal antibody specific for canine CD25 (P4A10): selection and evaluation of canine Tregs.
Vet. Immunol. Immunopathol., Jun;135(3-4):257-65 (2010)
Delaying DLA-haploidentical hematopoietic cell transplantation after total body irradiation.
Biol. Blood Marrow Transplant., Oct;15(10):1244-50 (2009)
Immunomodulatory effects of mixed hematopoietic chimerism: immune tolerance in canine model of lung transplantation.
Am. J. Transplant., May;9(5):1037-47 (2009)
Adoptive immunotherapy against allogeneic kidney grafts in dogs with stable hematopoietic trichimerism.
Biol. Blood Marrow Transplant., Nov;14(11):1201-8 (2008)
Intussusception in canine recipients of hematopoietic cell grafts and surgical correction.
Comp. Med., Jun;57(3):287-91 (2007)
Stable trichimerism after marrow grafting from 2 DLA-identical canine donors and nonmyeloablative conditioning.
Blood., Jul;110(1):418-23 (2007)
Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia.
Biol. Blood Marrow Transplant., Mar;13(3):355-65 (2007)
Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma.
Biol. Blood Marrow Transplant., Apr;13(4):423-32 (2007)
Partial donor-specific tolerance to delayed skin grafts after rejection of hematopoietic cell graft.
Transplantation., Sep;82(5):629-37 (2006)
Denileukin diftitox as prophylaxis against graft-versus-host disease in the canine hematopoietic cell transplantation model.
Biol. Blood Marrow Transplant., Sep;12(9):899-904 (2006)
Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis.
Arthritis Rheum., Jun;54(6):1982-6 (2006)
Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation.
Blood., Dec;106(13):4381-8 (2005)
Adoptive immunotherapy to increase the level of donor hematopoietic chimerism after nonmyeloablative marrow transplantation for severe canine hereditary hemolytic anemia.
Biol. Blood Marrow Transplant., Nov;9(11):674-82 (2003)
Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model.
J. Clin. Invest., Nov;112(10):1581-8 (2003)
Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases.
Biol. Blood Marrow Transplant., Sep;9(9):583-91 (2003)
Minor histocompatibility antigen-specific cytotoxic T lymphocytes generated with dendritic cells from DLA-identical littermates.
Biol. Blood Marrow Transplant., Apr;9(4):234-42 (2003)
FLT3 ligand promotes engraftment of allogeneic hematopoietic stem cells without significant graft-versus-host disease.
Transplantation., Apr;75(7):933-40 (2003)
Adoptive immunotherapy against kidney targets in dog-leukocyte antigen-identical mixed hematopoietic canine chimeras.
Transplantation., Feb;75(3):268-74 (2003)
Review of "minitransplantation": nonmyeloablative allogeneic hematopoietic stem cell transplantation.
Int. J. Hematol., Jan;77(1):3-14 (2003)
Survival of small bowel transplants in canine mixed hematopoietic chimeras: preliminary results.
Transplant. Proc., Dec;34(8):3366-7 (2002)
Effect of c-mpl ligands after total body irradiation (TBI) with and without allogeneic hematopoietic stem cell transplantation: low-dose TBI does not prevent sensitization.
Biol. Blood Marrow Transplant., 8(7):360-7 (2002)
Stem cell transplantation for aplastic anemia.
Int. J. Hematol., Feb;75(2):141-6 (2002)
Dr. George Georges M